These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28007570)

  • 101. Oleoylethanolamide increases the expression of PPAR-Α and reduces appetite and body weight in obese people: A clinical trial.
    Laleh P; Yaser K; Abolfazl B; Shahriar A; Mohammad AJ; Nazila F; Alireza O
    Appetite; 2018 Sep; 128():44-49. PubMed ID: 29787831
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
    Goldstone AP; Holland AJ; Butler JV; Whittington JE
    Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The Prader-Willi syndrome murine imprinting center is not involved in the spatio-temporal transcriptional regulation of the Necdin gene.
    Watrin F; Le Meur E; Roeckel N; Ripoche MA; Dandolo L; Muscatelli F
    BMC Genet; 2005 Jan; 6():1. PubMed ID: 15634360
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Oleoylethanolamide attenuates apoptosis by inhibiting the TLR4/NF-κB and ERK1/2 signaling pathways in mice with acute ischemic stroke.
    Zhou H; Yang WS; Li Y; Ren T; Peng L; Guo H; Liu JF; Zhou Y; Zhao Y; Yang LC; Jin X
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):77-84. PubMed ID: 27738712
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration.
    Antón M; Alén F; Gómez de Heras R; Serrano A; Pavón FJ; Leza JC; García-Bueno B; Rodríguez de Fonseca F; Orio L
    Addict Biol; 2017 May; 22(3):724-741. PubMed ID: 26857094
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.
    Bizzarri C; Rigamonti AE; Giannone G; Berardinelli R; Cella SG; Cappa M; Müller EE
    Horm Metab Res; 2004 Mar; 36(3):164-9. PubMed ID: 15057669
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The hypophagic factor oleoylethanolamide differentially increases c-fos expression in appetite regulating centres in the brain of wild type and histamine deficient mice.
    Umehara H; Fabbri R; Provensi G; Passani MB
    Pharmacol Res; 2016 Nov; 113(Pt A):100-107. PubMed ID: 27543461
    [TBL] [Abstract][Full Text] [Related]  

  • 108. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
    Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Mechanisms of obesity in Prader-Willi syndrome.
    Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
    Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Caralluma fimbriata extract activity involves the 5-HT2c receptor in PWS Snord116 deletion mouse model.
    Griggs JL; Mathai ML; Sinnayah P
    Brain Behav; 2018 Dec; 8(12):e01102. PubMed ID: 30353709
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration.
    Oveisi F; Gaetani S; Eng KT; Piomelli D
    Pharmacol Res; 2004 May; 49(5):461-6. PubMed ID: 14998556
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Oxytocin receptors in the Magel2 mouse model of autism: Specific region, age, sex and oxytocin treatment effects.
    Gigliucci V; Busnelli M; Santini F; Paolini C; Bertoni A; Schaller F; Muscatelli F; Chini B
    Front Neurosci; 2023; 17():1026939. PubMed ID: 36998737
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Oleoylethanolamide-induced anorexia in rats is associated with locomotor impairment.
    Fedele S; Arnold M; Krieger JP; Wolfstädter B; Meyer U; Langhans W; Mansouri A
    Physiol Rep; 2018 Feb; 6(3):. PubMed ID: 29388342
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth.
    Lee S; Walker CL; Karten B; Kuny SL; Tennese AA; O'Neill MA; Wevrick R
    Hum Mol Genet; 2005 Mar; 14(5):627-37. PubMed ID: 15649943
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Deactivation of the left dorsolateral prefrontal cortex in Prader-Willi syndrome after meal consumption.
    Reinhardt M; Parigi AD; Chen K; Reiman EM; Thiyyagura P; Krakoff J; Hohenadel MG; Le DS; Weise CM
    Int J Obes (Lond); 2016 Sep; 40(9):1360-8. PubMed ID: 27121248
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation.
    Soria-Gómez E; Guzmán K; Pech-Rueda O; Montes-Rodríguez CJ; Cisneros M; Prospéro-García O
    Pharmacol Res; 2010 May; 61(5):379-84. PubMed ID: 20100574
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice.
    Thabuis C; Destaillats F; Lambert DM; Muccioli GG; Maillot M; Harach T; Tissot-Favre D; Martin JC
    J Lipid Res; 2011 Jul; 52(7):1373-82. PubMed ID: 21515921
    [TBL] [Abstract][Full Text] [Related]  

  • 118. The effects of oleoylethanolamide, an endogenous PPAR-α agonist, on risk factors for NAFLD: A systematic review.
    Tutunchi H; Ostadrahimi A; Saghafi-Asl M; Maleki V
    Obes Rev; 2019 Jul; 20(7):1057-1069. PubMed ID: 31111657
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Gastric Bypass Surgery Recruits a Gut PPAR-α-Striatal D1R Pathway to Reduce Fat Appetite in Obese Rats.
    Hankir MK; Seyfried F; Hintschich CA; Diep TA; Kleberg K; Kranz M; Deuther-Conrad W; Tellez LA; Rullmann M; Patt M; Teichert J; Hesse S; Sabri O; Brust P; Hansen HS; de Araujo IE; Krügel U; Fenske WK
    Cell Metab; 2017 Feb; 25(2):335-344. PubMed ID: 28065827
    [TBL] [Abstract][Full Text] [Related]  

  • 120. NAPE-PLD controls OEA synthesis and fat absorption by regulating lipoprotein synthesis in an in vitro model of intestinal epithelial cells.
    Igarashi M; Watanabe K; Tsuduki T; Kimura I; Kubota N
    FASEB J; 2019 Mar; 33(3):3167-3179. PubMed ID: 30399323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.